InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Hanna, John Gordon. Director active across 1 company, notably HLS Therapeutics Inc.. Aggregated, 4 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €15k. History available since 16 June 2026. The latest transaction was filed on 1 September 2026 (10 - Acquisition or disposition in the public market). Regulator: SEDI. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
John Gordon Hanna is a declarant linked to HLS Therapeutics Inc. (XTSE), where he is listed as 4 - Director of Issuer, 5 - Senior Officer of Issuer. His record shows 3 filings in total, and across the 3 sampled recent filings from 2026-06-17 to 2026-06-30, the buy amount is EUR 10592 with no reported sales; the most common transaction nature is 56 - Grant of rights.